Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.12.16
智信：关于监事离任的公告
2025.12.16
智信：关于选举职工董事的公告
2025.12.16
智信：2025年第一次临时股东会决议公告
2025.12.05
智信：关于延长员工持股计划存续期的公告
2025.12.05
智信：第六届董事会第十九次会议决议公告
2025.11.24
智信：深圳市智信药业集团股份有限公司关于召开2025年第一次临时股东会的通知
2025.11.24
智信：关于独立董事任期届满离任暨补选独立董事的公告
2025.11.24
智信：公司章程
2025.11.24
智信：独立董事提名人声明与承诺（浦洪）
2025.11.24
智信：独立董事候选人声明与承诺（浦洪）
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
